Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evaxion A/S - American Depositary Share (NQ:EVAX)

5.460 -0.250 (-4.38%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evaxion A/S - American Depositary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01
From Evaxion Biotech
Via GlobeNewswire
News headline image
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to... 
Via Benzinga
News headline image
Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Biotech Highlights Promising Data From Personalized Cancer Immunotherapy ↗
 
Via Benzinga
News headline image
Recap: Evaxion Biotech Q2 Earnings ↗
  Evaxion Biotech (NASDAQ:EVAX) reported its Q2 earnings results on Wednesday, August 10, 2022 at 08:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Evaxion, ExpreS2ion Ink Research Pact For Cytomegalovirus Vaccine Candidate ↗
 
Via Benzinga
News headline image
Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Announces Third Quarter 2022 Financial Results and Business Update
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion Biotech To Test EVX-03 DNA Vaccine For Non-Small Cell Lung Cancer ↗
 
Via Benzinga
News headline image
Evaxion CEO comments on strategic focus
From Evaxion Biotech
Via GlobeNewswire
News headline image
Evaxion welcomes Per Norlén as new CEO.
From Evaxion Biotech
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
US Stocks Open Higher; Dow Surges 300 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday. 
Via Benzinga
News headline image
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement. 
Via InvestorPlace
News headline image
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem... 
Via Benzinga
News headline image
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
US Stocks Edge Higher As Fed Raises Interest Rates By 75 Basis Points ↗
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed. 
Via Benzinga
News headline image
Why Is Evaxion Biotech (EVAX) Stock Up Today? ↗
Today's news that Evaxion Biotech has enrolled its first patient in a key clinical trial has sent shares of EVAX stock soaring today. 
Via InvestorPlace
News headline image
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
S&P 500 Rises 0.5%; Crude Oil Falls Sharply ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Wednesday. 
Via Benzinga
News headline image
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.